15 – 21 December 2012

John Edmunds and Alma Adler speak to Sky News about preliminary findings from the UK Flusurvey: “The data are very preliminary and flu levels are still very low but overall the results suggest that contrary to what we expected to find, there is no such thing as man flu.”Also…

Read more

8 – 14 December 2012

Peter Piot and Sandy Cairncross speak to BBC News about the global burden of disease. Also covered by Reuters and numerous titles worldwide.

Brendan Wren in the Guardian on tracking the origins of the UK outbreak of C. Difficile: “Since these strains acquired resistance to this frontline antibiotic, not only…

Read more

1 – 7 December 2012

Virginia Berridge speaks to BBC Wales about the tobacco display ban coming into force in Wales: “A reduction might be achieved but a smoke-free society is probably unrealistic. If we look at an area that is increasing parallel – the ‘war on drugs’ approach – that hasn’t achieved nil consumption…

Read more

24 – 30 November 2012

Alma Adler speaks to BBC News about man flu and the UK Flusurvey: “We haven’t found any evidence of ‘man flu’ yet. The biggest risk factor is having children under the age of 18 and for this reason women are more at risk of flu. This year we have…

Read more

17 – 23 November 2012

Alma Adler in the Telegraph for the launch of the UK Flusurvey and the risk of catching flu on your daily commute: “Last year we found no difference in the chance of reporting a flu-like illness in people who took public transport and people who did not. In fact…

Read more

10 – 16 November 2012

Martin McKee speaks to Reuters about calls for a global treaty to stop the lethal trade in fake medicines:  “We hope that this will form the basis for getting some consensus on a definition of counterfeit drugs, which would then be transferable into a legal instrument.” Also covered by more…

Read more

3 – 9 November 2012

Eleanor Riley speaks to Reuters about the latest results of the RTS,S vaccine study: “We’re all a bit frustrated that it has proven so hard to make a malaria vaccine. The question is how much money are the funders willing to keep throwing at it.” Also covered by…

Read more

27 October – 2 November 2012

Kara Hanson in the Irish Journal on research to evaluate the Affordable Medicines Facility for malaria (AMFm): “Tapping into the private sector distribution chain can have a major influence on which antimalarial treatments are available and their price and quality in just a few months.” The Lancet study (and Comment…

Read more

29 September – 26 October 2012

Highlights: 20-26 October 2012

Val Curtis, Jeroen Ensink and Eileen Chappell speak to IRIN about LSHTM work on sanitation and hygiene: “We have a lot of people working on disgust. We have people doing PhDs, writing books on disgust, and why people are disgusted by things. People say, ‘Oh…

Read more

1 September – 28 September 2012

Highlights: 22-28 September 2012

Anne Mills on Voice of America on the fall in funding for maternal and child health: “If that continues into the future, then I certainly think it’s of major concern.  Ultimately that may have an impact in terms of maternal deaths, neo-natal deaths…

Read more